L. E. Mitchell, N. S. Adzick, J. Melchionne, P. S. Pasquariello, L. N. Sutton et al., Lancet, vol.364, issue.9448, pp.1885-95, 2004.

X. Gamé, F. Grima, E. Chartier-kastler, and A. Ruffion, Vesicosphincteric and sexual disorders associated with spina bifida and myelomeningocele, Prog Urol, vol.17, issue.3, pp.352-359, 2007.

P. W. Veenboer, J. Bosch, F. Van-asbeck, and L. De-kort, Upper and lower urinary tract outcomes in adult myelomeningocele patients: a systematic review, PloS One, vol.7, issue.10, p.48399, 2012.

G. M. Hunt, A study of deaths and handicap in a consecutive series of spina bifida treated unselectively from birth, Z Kinderchir, vol.38, issue.2, pp.100-102, 1983.

B. Singhal and K. M. Mathew, Factors affecting mortality and morbidity in adult spina bifida, Eur J Pediatr Surg, vol.9, issue.1, pp.31-33, 1999.

G. V. Mcdonnell and J. P. Mccann, Why do adults with spina bifida and hydrocephalus die? A clinic-based study, Eur J Pediatr Surg, vol.10, issue.1, pp.31-33, 2000.

G. S. Liptak, K. Garver, and N. P. Dosa, Spina bifida grown up, J Dev Behav Pediatr, vol.34, issue.3, pp.206-221, 2013.

T. Boudemaghe and I. Belhadj, Data Resource Profile: The French National Uniform Hospital Discharge Data Set Database (PMSI), Int J Epidemiol, vol.46, issue.2, pp.392-392, 2017.

P. Oakeshott, F. Reid, A. Poulton, H. Markus, R. H. Whitaker et al., Neurological level at birth predicts survival to the mid-40s and urological deaths in open spina bifida: a complete prospective cohort study, Dev Med Child Neurol, vol.57, issue.7, pp.634-638, 2015.

P. W. Veenboer, L. M. De-kort, R. J. Chrzan, and T. P. De-jong, Urinary considerations for adult patients with spinal dysraphism, Nat Rev Urol, vol.12, issue.6, p.331, 2015.

J. J. Duplisea, R. L. Romao, D. L. Maclellan, A. R. Cox, and P. A. Anderson, Urological Follow-up in

, Adult Spina Bifida Patients: Is There an Ideal Interval?, Urology, vol.97, pp.269-272, 2016.

P. Madhuvrata, M. Singh, Z. Hasafa, A. , and M. , Anticholinergic drugs for adult neurogenic detrusor overactivity: a systematic review and meta-analysis, Eur Urol, vol.62, issue.5, pp.816-846, 2012.

B. Peyronnet, X. Gamé, G. Vurture, V. W. Nitti, and B. M. Brucker, Botulinum Toxin Use in Neurourology, Rev Urol, vol.20, issue.2, pp.84-93, 2018.

S. Musco, B. Padilla-fernández, D. Popolo, and G. , Value of urodynamic findings in predicting upper urinary tract damage in neuro-urological patients: A systematic review

, Neurourol Urodyn, vol.37, issue.5, 2018.

U. Nseyo and Y. Santiago-lastra, Long-Term Complications of the Neurogenic Bladder, Urol Clin North Am, vol.44, issue.3, pp.355-366, 2017.

J. Lapides, A. C. Diokno, S. J. Silber, and B. S. Lowe, Clean, intermittent self-catheterization in the treatment of urinary tract disease, J Urol, vol.107, issue.3, pp.458-61, 1972.

I. M. Thompson and R. Lauvetz, Oxybutynin in bladder spasm, neurogenic bladder, and enuresis, Urology, vol.8, issue.5, pp.452-456, 1976.

G. Savic, M. J. Devivo, H. L. Frankel, M. A. Jamous, B. M. Soni et al., Causes of death after traumatic spinal cord injury-a 70-year British study, Spinal Cord, vol.55, issue.10, pp.891-897, 2017.

B. Peyronnet, A. Even, and G. Capon, Intradetrusor Injections of Botulinum Toxin A in Adults with Spinal Dysraphism, J Urol, vol.200, issue.4, pp.875-880, 2018.

M. Baron, B. Peyronnet, and A. Aublé, Long-Term Discontinuation of Botulinum Toxin A Intradetrusor Injections for Neurogenic Detrusor Overactivity: A Multicenter Study, J Urol, vol.201, issue.4, pp.769-776, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02312573

E. Malm-buatsi, C. E. Aston, and J. Ryan, Mental health and parenting characteristics of caregivers of children with spina bifida, J Pediatr Urol, vol.11, issue.2, pp.65-66, 2015.

A. M. Psihogios, C. Murray, K. Zebracki, L. Acevedo, and G. N. Holmbeck, Testing the Utility of a

. Bio-neuropsychosocial, Model for Predicting Medical Adherence and Responsibility During Early Adolescence in Youth With Spina Bifida, J Pediatr Psychol, vol.42, issue.9, pp.910-921, 2017.

V. Héon-klin, European Reference networks for rare diseases: what is the conceptual framework?, Orphanet J Rare Dis, vol.12, issue.1, p.137, 2017.

É. Monnet and F. Chauvin, Health care delivery for patients with rare diseases Rev Prat, vol.67, pp.569-573, 2017.

A. B. Rodrigues, V. L. Krebs, H. Matushita, and W. B. De-carvalho, Short-term prognostic factors in myelomeningocele patients, Childs Nerv Syst, vol.32, issue.4, pp.675-80, 2016.